Gagnon Securities Trims Freshworks Position Amid Year-Long Decline

The Motley FoolThe Motley Fool
|||1 min read
Key Takeaway

Gagnon Securities sells $7.51M in Freshworks shares, reducing stake to 3.1%. Stock down 60% yearly, but company shows 16% revenue growth and improved profitability.

Gagnon Securities Trims Freshworks Position Amid Year-Long Decline

Gagnon Securities has reduced its stake in Freshworks through a $7.51 million share sale, offloading 635,807 shares and bringing its portfolio allocation down to 3.1% of total assets. The transaction occurs against a backdrop of significant stock depreciation, with Freshworks shares declining 60% over the past twelve months.

Despite the equity weakness, Freshworks has demonstrated operational resilience. The company posted 16% year-over-year revenue growth and achieved improved profitability metrics during the same period, indicating underlying business strength independent of market sentiment.

The share reduction appears consistent with portfolio rebalancing activity rather than a negative reassessment of the company's fundamentals. The move allows Gagnon Securities to reallocate capital while maintaining a meaningful position in the software-as-a-service provider.

Source: The Motley Fool

Back to newsPublished Feb 16

Related Coverage

The Motley Fool

Nebius Eyes $7-9B Revenue by 2026 as AI Cloud Growth Accelerates

Nebius reports 547% YoY revenue growth to $228M in Q4, projects $7-9B ARR by 2026, but operates at major losses amid data center expansion.

NVDAMETAMSFT
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
Investing.com

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.

QBTS
GlobeNewswire Inc.

OneMain Holdings Faces Multi-State Securities Probe Over Alleged Lending Fraud

Pomerantz Law Firm investigates $OMF following multi-state lawsuit alleging deceptive lending practices. Stock tumbles 5.38% on fraud allegations.

OMF
The Motley Fool

Integer Stock Tumbles 28% as Insider Liquidates Holdings Amid Leverage Concerns

Integer Holdings shares fell 28% as insider sold $70k in stock amid concerns over elevated 3.0x leverage and margin sustainability despite 8% revenue growth to $1.85B.

ITGR
GlobeNewswire Inc.

Boston Scientific Faces Securities Fraud Lawsuit Over Overstated EP Growth Claims

Boston Scientific faces class action lawsuit alleging material misstatements about electrophysiology growth. Stock fell 17.6% after disclosing slower market growth and competitive pressures.

BSX